|
|||||
|
|
Impact of delayed initiation of erythropoietin in critically ill patients |
|
| Authors: | Jeremiah J Duby Brian L Erstad Jacob Abarca James M Camamo Yvonne Huckleberry Stuart N Bramblett |
| Affiliation: | (1) Inpatient Pharmacy Department, Kaiser Permanente, 975 Sereno Dr, Vallejo, CA 94589, USA;(2) Department of Pharmacy Practice & Science- Pulido, The University of Arizona College of Pharmacy, 1295 N. Martin, Tucson, AZ 85721, USA;(3) WellPoint NextRx, 8401 Fallbrook Ave./MS CAAF01-0007, West Hills, CA 91304, USA;(4) University Medical Center, 1501 N. Campbell Avenue, Tucson, AZ 85724, USA |
| Abstract: | BackgroundThe purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |